DK2822965T3 - FREMGANGSMÅDE TIL BERIGELSE AF IgA - Google Patents
FREMGANGSMÅDE TIL BERIGELSE AF IgA Download PDFInfo
- Publication number
- DK2822965T3 DK2822965T3 DK13708164.2T DK13708164T DK2822965T3 DK 2822965 T3 DK2822965 T3 DK 2822965T3 DK 13708164 T DK13708164 T DK 13708164T DK 2822965 T3 DK2822965 T3 DK 2822965T3
- Authority
- DK
- Denmark
- Prior art keywords
- iga
- enrichment
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12158927.9A EP2636681A1 (en) | 2012-03-09 | 2012-03-09 | Process for enriching IgA |
PCT/EP2013/054698 WO2013132053A1 (en) | 2012-03-09 | 2013-03-08 | Process for enriching iga |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2822965T3 true DK2822965T3 (da) | 2022-07-11 |
Family
ID=47843296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13708164.2T DK2822965T3 (da) | 2012-03-09 | 2013-03-08 | FREMGANGSMÅDE TIL BERIGELSE AF IgA |
Country Status (10)
Country | Link |
---|---|
US (1) | US9828418B2 (da) |
EP (2) | EP2636681A1 (da) |
JP (1) | JP6259777B2 (da) |
KR (1) | KR102079487B1 (da) |
CN (1) | CN104245728B (da) |
AU (1) | AU2013201388B2 (da) |
DK (1) | DK2822965T3 (da) |
ES (1) | ES2919861T3 (da) |
HK (1) | HK1202881A1 (da) |
WO (1) | WO2013132053A1 (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2822967T3 (da) | 2012-03-09 | 2019-10-07 | Csl Behring Ag | Compositions comprising secretory - like immunoglobulins |
EP2636684A1 (en) * | 2012-03-09 | 2013-09-11 | CSL Behring AG | Prevention of infection |
JP6474798B2 (ja) * | 2013-07-01 | 2019-02-27 | ツェー・エス・エル・ベーリング・アクチエンゲゼルシャフト | 方法 |
GB201413227D0 (en) | 2014-07-25 | 2014-09-10 | Bioproducts Lab Ltd | Process |
DE202014105749U1 (de) * | 2014-11-27 | 2015-01-09 | iCradle GmbH | Daumenschalter zur Befestigung an einem Fahrradlenker und über einen derartigen Daumenschalter bedienbares Steuersystem für ein Fahrrad |
WO2017078947A1 (en) * | 2015-10-21 | 2017-05-11 | Cambryn Biologics, Llc | Processes for purifying proteins from plasma |
WO2018115048A1 (en) | 2016-12-20 | 2018-06-28 | Csl Behring Ag | Methods for affecting salmonella infections |
JP2020534370A (ja) | 2017-09-21 | 2020-11-26 | ユーエムセー ユトレヒト ホールディング ベイフェイUMC Utrecht Holding B.V. | 神経芽腫の治療のための抗gd2抗体 |
JP7174072B2 (ja) * | 2018-05-17 | 2022-11-17 | ツェー・エス・エル・ベーリング・アクチエンゲゼルシャフト | タンパク質抽出方法およびシステム |
EP3886902A1 (en) | 2018-11-30 | 2021-10-06 | CSL Behring AG | Methods and compositions for preventing or treating acute exacerbations with polyclonal immunoglobulin |
CA3131705A1 (en) | 2019-03-27 | 2020-10-01 | Umc Utrecht Holding B.V. | Engineered iga antibodies and methods of use |
CN112574296B (zh) * | 2020-12-30 | 2023-05-19 | 中国医学科学院输血研究所 | 一种模拟IVIg的多人份混合人血浆IgG样品的分离纯化方法 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5500345A (en) * | 1989-04-25 | 1996-03-19 | Iatron Laboratories, Inc. | Hybridomas producing monoclonal antibodies specific for C-reactive protein and methods for detection of C-reactive protein |
DE3927111C3 (de) * | 1989-08-17 | 1994-09-01 | Biotest Pharma Gmbh | Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate |
US5258177A (en) * | 1991-12-10 | 1993-11-02 | Alpha Therapeutic Corporation | IgA preparation and process of making the same |
FR2706466B1 (fr) | 1993-06-14 | 1995-08-25 | Aetsrn | Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré. |
WO1995004081A1 (en) | 1993-07-30 | 1995-02-09 | Oravax, Inc. | MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS |
DE19600939C1 (de) | 1996-01-12 | 1997-08-28 | Immuno Ag | Verfahren zur Trennung von IgG und IgA |
EP0839915A1 (en) | 1996-11-01 | 1998-05-06 | Institut Suisse De Recherches Experimentales Sur Le Cancer Isrec | Secretory immunoglobulin A as a mucosal vaccine delivery system |
US6300104B1 (en) | 1997-06-19 | 2001-10-09 | The Regents Of The University Of California | Secretory immunoglobulin produced by single cells and methods for making and using same |
US5886154A (en) | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
US20020114802A1 (en) | 1998-02-10 | 2002-08-22 | Tjellstrom Bo Arthur Einar | Oral immunoglobulin treatment for inflammatory bowel disease |
ES2229784T3 (es) | 1998-06-09 | 2005-04-16 | Statens Serum Institut | Proceso de produccion de inmunoglobulinas para administracion intravenosa y otros productos de inmunoglobulina. |
JP2000103800A (ja) | 1998-09-29 | 2000-04-11 | Yoshitomi Pharmaceut Ind Ltd | 免疫グロブリンaの精製方法 |
AUPP806999A0 (en) * | 1999-01-08 | 1999-02-04 | Csl Limited | Process for purifying immunoglobulins |
EP1068871A1 (en) | 1999-07-07 | 2001-01-17 | Jean-Paul Perraudin | Novel methods and medicament for treating infections diseases involving microbial biofilms |
ES2292493T3 (es) | 1999-12-13 | 2008-03-16 | Universidad Nacional Autonoma De Mexico | Metodo inmunoenzimatico de cuantificacion. |
NZ527977A (en) | 2001-02-12 | 2005-10-28 | Medarex Inc | Human monoclonal antibodies to FC alpha receptor (CD89) |
US6932967B2 (en) | 2001-03-22 | 2005-08-23 | Michael R. Simon | Human medical treatment by aerosol inhalation of immunoglobulin A |
FR2824568B1 (fr) | 2001-05-11 | 2004-04-09 | Lab Francais Du Fractionnement | Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique |
US7737260B2 (en) | 2003-11-13 | 2010-06-15 | Hanmi Pharm. Co., Ltd | Protein complex using an immunoglobulin fragment and method for the preparation thereof |
US20060165675A1 (en) | 2002-08-02 | 2006-07-27 | Richman-Eisenstat Janice Beth | Modulation of mesenchymal cells via iga-receptors |
US8021645B2 (en) | 2006-12-13 | 2011-09-20 | Simon Michael R | Synthesis of human secretory IgA and IgM and the formation of a medicament therefrom |
US7794721B2 (en) | 2006-12-13 | 2010-09-14 | Simon Michael R | Synthesis of human secretory IgM and the treatment of clostridium difficile associated diseases herewith |
US8709413B2 (en) | 2006-12-13 | 2014-04-29 | Michael R. Simon | Treatment of celiac disease with IgA |
US8119104B2 (en) | 2006-12-13 | 2012-02-21 | Michael R. Simon | Treatment of celiac disease with IgA |
US7597891B2 (en) | 2006-12-13 | 2009-10-06 | Simon Michael R | Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases |
US8313730B2 (en) | 2006-12-13 | 2012-11-20 | Michael R. Simon | Treatment of celiac disease with IgA |
US20080145420A1 (en) | 2006-12-13 | 2008-06-19 | Simon Michael R | HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES |
EP2244735A4 (en) | 2007-10-02 | 2011-02-23 | Avaxia Biologics Inc | ANTIBODY THERAPY FOR USE IN THE DIGESTIVE TUBE |
CN102124027B (zh) | 2008-05-15 | 2015-01-21 | 温氏健康有限公司 | 产生富含分泌型免疫球蛋白的乳组分的方法 |
GB201006753D0 (en) | 2010-04-22 | 2010-06-09 | Biotest Ag | Process for preparing an immunolobulin composition |
EP2465536A1 (en) | 2010-12-14 | 2012-06-20 | CSL Behring AG | CD89 activation in therapy |
CN104136121B (zh) * | 2012-02-14 | 2017-04-19 | 生物辐射实验室股份有限公司 | 减少离子交换色谱中的pH漂移 |
EP2636684A1 (en) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Prevention of infection |
EP2636683A1 (en) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Treatment of mucositis with Immunoglobulin |
DK2822967T3 (da) | 2012-03-09 | 2019-10-07 | Csl Behring Ag | Compositions comprising secretory - like immunoglobulins |
WO2013158279A1 (en) * | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Protein purification methods to reduce acidic species |
-
2012
- 2012-03-09 EP EP12158927.9A patent/EP2636681A1/en not_active Ceased
-
2013
- 2013-03-08 JP JP2014560388A patent/JP6259777B2/ja active Active
- 2013-03-08 AU AU2013201388A patent/AU2013201388B2/en active Active
- 2013-03-08 US US14/377,535 patent/US9828418B2/en active Active
- 2013-03-08 KR KR1020147028263A patent/KR102079487B1/ko active IP Right Grant
- 2013-03-08 WO PCT/EP2013/054698 patent/WO2013132053A1/en active Application Filing
- 2013-03-08 DK DK13708164.2T patent/DK2822965T3/da active
- 2013-03-08 CN CN201380013075.7A patent/CN104245728B/zh active Active
- 2013-03-08 ES ES13708164T patent/ES2919861T3/es active Active
- 2013-03-08 EP EP13708164.2A patent/EP2822965B1/en active Active
-
2015
- 2015-04-08 HK HK15103456.4A patent/HK1202881A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US9828418B2 (en) | 2017-11-28 |
JP6259777B2 (ja) | 2018-01-10 |
WO2013132053A1 (en) | 2013-09-12 |
JP2015509523A (ja) | 2015-03-30 |
EP2822965B1 (en) | 2022-05-11 |
US20150005476A1 (en) | 2015-01-01 |
KR20140136028A (ko) | 2014-11-27 |
CN104245728A (zh) | 2014-12-24 |
EP2822965A1 (en) | 2015-01-14 |
EP2636681A1 (en) | 2013-09-11 |
AU2013201388B2 (en) | 2015-09-03 |
CN104245728B (zh) | 2017-11-28 |
AU2013201388A1 (en) | 2013-09-26 |
HK1202881A1 (en) | 2015-10-09 |
KR102079487B1 (ko) | 2020-02-21 |
ES2919861T3 (es) | 2022-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3454346T3 (da) | Anordning til cylotronfremstilling af technetium-99m | |
DK2906696T4 (da) | Fremgangsmåder til modulering af c9orf72-ekspression | |
DK2822965T3 (da) | FREMGANGSMÅDE TIL BERIGELSE AF IgA | |
DK3225604T3 (da) | Fremgangsmåde til fremstilling af flerlagsruder | |
DK3824991T3 (da) | Fremgangsmåde til forberedelse af lithiumsulfat | |
DK2730878T3 (da) | Pladestak og fremgangsmåde til fremstilling af en pladestak | |
DK2895156T3 (da) | Fremgangsmåde til fremstilling af terapeutiske nanopartikler | |
DK2934251T3 (da) | Indretning til fremstilling af mælkeskum | |
DK2718404T3 (da) | Fremgangsmåde til fremstilling af flydende carbonhydrider | |
DK3520805T3 (da) | Sammensætninger til behandling af myelofibrose | |
DK2874506T3 (da) | Fremgangsmåde til fremstilling af enzymgranulater | |
DK3689853T3 (da) | Fremgangsmåde til syntese af thyreoideahormonanaloger og polymorfer deraf | |
DK3010895T3 (da) | Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner | |
DK2953904T3 (da) | Fremgangsmåde til kontrolleret fremstilling af et biocid | |
DK2623288T3 (da) | Fremgangsmåde til fremstilling af formstøbte skumdele | |
DK2931188T3 (da) | Støtte til forebyggelse af symptomer på femoro acetabulær indeklemning | |
DK3680000T3 (da) | Fremgangsmåder til oprensning af antistoffer | |
DK2836460T3 (da) | Fremgangsmåde til fremstilling af graphen | |
DK2728009T3 (da) | Fremgangsmåde til fremstilling af monosaccharider | |
DK2919777T3 (da) | Transmukosal afgivelse af tocotrienol | |
DK2931313T3 (da) | Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer | |
DK2985275T3 (da) | Fremgangsmåde til oprensning af beta-hydroxy-beta-methylsmørsyre | |
DK2872536T3 (da) | Fremgangsmåde til ekstraktion af biomasse | |
DK2906219T3 (da) | Orvepitant til behandling af kronisk pruritus | |
DK2701707T3 (da) | Fremgangsmåde til behandling af dyskinesi |